Literature DB >> 16086322

The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences.

Françoise Charbonnier1, Stephanie Baert-Desurmont, Ping Liang, Frederic Di Fiore, Cosette Martin, Stephanie Frerot, Sylviane Olschwang, Qing Wang, Marie-Pierre Buisine, Brigitte Gilbert, Mef Nilbert, Annika Lindblom, Thierry Frebourg.   

Abstract

MSH2 rearrangements are involved in approximately 10% of hereditary non-polyposis colorectal cancer (HNPCC) families, and in most of the rearrangements, exon 1 is deleted. We scanned by quantitative multiplex polymerase chain reaction (PCR) of short fluorescent fragments (QMPSF) 200 kb of genomic sequences upstream of the MSH2 transcription initiation site in 21 HNPCC families with exon 1 deletions. This QMPSF scan revealed 12 distinct 5' breakpoints located up to 200 kb upstream of the MSH2 transcription initiation site. Sequencing analysis of the rearranged allele in 17 families revealed that most of the deletions (15/17) resulted from homologous Alu-mediated recombination. QMPSF and sequencing analysis in these 21 families led us to detect the presence of 20 distinct 5' breakpoints. In 14 out of 15 Alu-mediated recombinations, we found, either within the identical region in which the recombination had probably occurred or in its vicinity, the 26-bp Alu core sequence containing the recombinogenic Chi-like motif. Compared to the equivalent regions of other human genes, the MSH2 upstream region was found to contain a high density of Alu repeats (30% within 228 kb and 43% within 50 kb), most of which belong to the old Alu S subfamilies. In conclusion, this study demonstrates the heterogeneity of the breakpoints within the MSH2 upstream region and reveals the remarkable density of recombinogenic Alu sequences in this region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086322     DOI: 10.1002/humu.20216

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.

Authors:  Janos Papp; Marietta E Kovacs; Edith Olah
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

2.  The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Authors:  J Tinat; S Baert-Desurmont; J B Latouche; S Vasseur; C Martin; E Bouvignies; T Frébourg
Journal:  Fam Cancer       Date:  2008-05-22       Impact factor: 2.375

Review 3.  EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Ad Geurts van Kessel; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  Huppke-Brendel syndrome in a seven months old boy with a novel 2-bp deletion in SLC33A1.

Authors:  Shwetha Chiplunkar; Parayil Sankaran Bindu; Madhu Nagappa; Cheminikara Bineesh; Periyasamy Govindaraj; Narayanappa Gayathri; M M Srinivas Bharath; Hanumanthapura R Arvinda; Pavagada S Mathuranath; Sanjib Sinha; Arun B Taly
Journal:  Metab Brain Dis       Date:  2016-06-15       Impact factor: 3.584

5.  A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.

Authors:  Kyle M Walsh; Murim Choi; Kjell Oberg; Matthew H Kulke; James C Yao; Chengqing Wu; Magdalena Jurkiewicz; Ling-I Hsu; Susanne M Hooshmand; Manal Hassan; Eva T Janson; Janet L Cunningham; Evan Vosburgh; Richard S Sackler; Richard P Lifton; Andrew T Dewan; Josephine Hoh
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

6.  A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42).

Authors:  Nina A Schlipf; Christian Beetz; Rebecca Schüle; Giovanni Stevanin; Anne Kjersti Erichsen; Sylvie Forlani; Cécile Zaros; Kathrin Karle; Stephan Klebe; Sven Klimpe; Alexandra Durr; Susanne Otto; Chantal M E Tallaksen; Olaf Riess; Alexis Brice; Peter Bauer; Ludger Schöls
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

7.  Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.

Authors:  Sana Aissi-Ben Moussa; Amel Moussa; Tonio Lovecchio; Nadia Kourda; Taoufik Najjar; Sarra Ben Jilani; Amel El Gaaied; Nicole Porchet; Mohamed Manai; Marie-Pierre Buisine
Journal:  Fam Cancer       Date:  2008-09-16       Impact factor: 2.375

8.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

9.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

10.  The contribution of alu elements to mutagenic DNA double-strand break repair.

Authors:  Maria E Morales; Travis B White; Vincent A Streva; Cecily B DeFreece; Dale J Hedges; Prescott L Deininger
Journal:  PLoS Genet       Date:  2015-03-11       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.